2026 Advanced Techniques in Targeted Prostate Biopsy and Focal Therapy in Prostate Cancer

As the management of localized prostate cancer shifts from whole-gland treatment toward more tailored interventions, the ability to accurately detect and localize disease is paramount. This comprehensive one-day course is designed for urologists seeking to master the novel approaches in diagnostics and treatment for prostate cancer care: the integration of advanced MRI-targeted diagnostics with novel focal therapy modalities.

The program begins by addressing the critical challenge of patient selection, utilizing multiparametric MRI (mpMRI) and PI-RADS v2.1 scoring to distinguish candidates for focal ablation from those requiring active surveillance or whole-gland treatment. Participants will explore the foundational role of mapping image-guided biopsies—including transperineal and fusion techniques—to accurately delineate tumor margins and ensure oncological control while preserving functional outcomes.

The program includes:

• Didactic Lectures: Expert faculty will provide evidence-based updates on High-intensity Focused Ultrasound (HIFU), genomic biomarkers, and the evolving role of AI in tumor mapping.

• Semi-Live Surgery: High-definition video-based surgical demonstrations will allow participants to observe real-time procedural steps, from patient positioning and energy delivery to intraprocedural monitoring.

• Panel-Based Case Discussions: Interactive sessions will feature multidisciplinary panels debating complex clinical scenarios, focusing on salvage strategies, surveillance protocols post-focal therapy, and the management of complications.

Participants are also invited to attend a networking reception following the accredited sessions. RSVP for the reception is recommended at the time of registration.

This course will be held in person only and is intended for urology faculty, fellows, and residents involved in the care of patients with prostate cancer.

1. Critically evaluate patient eligibility for focal therapy by integrating mpMRI findings (PI-RADS v2.1), genomic biomarkers, and biopsy data to differentiate between candidates for ablation and those requiring radical intervention
2. Execute precise MRI-ultrasound fusion techniques to improve the detection of clinically significant prostate cancer while minimizing the detection of indolent disease.
3. Design accurate focal ablation treatment zones by applying evidence-based safety margins (5–10mm) to targeted mapping data to ensure oncological control of the index lesion.
4. Implement a standardized post-treatment surveillance protocol using PSA kinetics and serial mpMRI to accurately monitor for recurrence and manage "salvage" decision-making.

This course is complimentary for all participants. Please select the Registration tab above and complete the form to confirm your attendance.

If you experience any difficulties during registering, or if you are registered and unable to attend, please email, [email protected] for assistance.

For details on our cancellation terms, please review our Cancellation Policy.

Please note that "industry professionals" are welcome to attend Continuing Medical Education events at MSK for their own educational purposes. View our Registration Policy for Industry Professionals for more information.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Hotels & Other Accommodations

If you are traveling to New York City from out of town, early hotel arrangements are strongly recommended.

A limited block of rooms has been secured at a preferred rate for course participants at the Courtyard by Marriott New York Manhattan/Central Park:

• Rate: $389 per night

• Dates: May 13–14 (option to extend stay through Thursday night)

• Booking: Reserve your room using the group registration link or call 855-331-8443 and reference Group Code: MSKMSKA

Please note that this special rate is available through Monday, April 20, 2026.

In addition, Memorial Sloan Kettering Cancer Center has arranged preferred rates and amenities at select Manhattan hotels. Click here to view participating hotels and additional details.

Travel and Parking

For information on traveling to MSK, including directions and parking options, click here. Please note that parking validation is not available for course attendees.

Accessibility

If you require any specific accommodations to attend this event in person, please contact [email protected] at least one week in advance.

Behfar Ehdaie, MD, MPH
Course Director 
Associate Attending Surgeon, Urology Service 
Memorial Sloan Kettering Cancer Center

Jonathan S. Fainberg, MD, MPH
Course Co-Director 
Assistant Attending Surgeon, Urology Service 
Memorial Sloan Kettering Cancer Center

Sean Fletcher, MD
Fellow Planner
Urologic Oncology Fellow 
Memorial Sloan Kettering Cancer Center

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.